Plan
Comptes Rendus

New nitro-benzo[c]phenanthridine and indolopyridoquinazoline alkaloids from Zanthoxylum atchoum
[Nouveaux alcaloïdes nitro-benzo[c]phénanthridines et indolopyridoquinazolines de Zanthoxylum atchoum]
Comptes Rendus. Chimie, Volume 18 (2015) no. 8, pp. 891-897.

Résumés

The first phytochemical investigation of the roots of Zanthoxylum atchoum has led to the isolation of two new nitro-benzo[c]phenanthridine alkaloids 6-nitronitidine (1) and 6-nitro-8-methoxy-7,8-dihydronitidine (2), two new salts of indolopyridoquinazoline alkaloids 3-hydroxy-8,13-dihydro-14-methyl-5-oxo-7H-indolo[2’,3’:3,4]pyrido[2,1-b]quinazolin-14-ium (3) and its zwitterionic form 3-phenolate-8,13-dihydro-14-methyl-5-oxo-7H-indolo[2’,3’:3,4]pyrido[2,1-b]quinazolin-14-ium (4) along with 18 (522) known compounds. Their chemical structures were elucidated by spectroscopic analysis including 1D and 2D NMR and MS techniques. This is the first report of the nitro group on the biosynthesis of the natural benzo[c]phenantridine alkaloids. Compound 2 exhibited potent antibacterial activity against Staphylococcus aureus of MIC50 = 4 μg·mL−1.

Supplementary Materials:
Supplementary material for this article is supplied as a separate file:

La première étude phytochimique des racines de Zanthoxylum atchoum a conduit à l’isolement de deux nouveaux alcaloïdes nitro-benzo[c]phénanthridine, le 6-nitronitidine (1) et 6-nitro-8-méthoxy-7,8-dihydronitidine (2), de deux nouveaux sels d’indolopyridoquinazoline, le 3-hydroxy-8,13-dihydro-14-méthyl-5-oxo-7H-indolo[2’,3’:3,4]pyrido[2,1-b]quinazolin-14-ium (3), et sa forme zwittérionique, le 3-phénolate de 8,13-dihydro-14-méthyl-5-oxo-7H-indolo [2’,3’:3,4]pyrido[2,1-b]quinazolin-14-ium (4), et de 18 composés connus (522). Leurs structures chimiques ont été élucidées par analyse des techniques spectroscopiques 1D et 2D-RMN et SM. C’est le premier rapport d’un groupement nitro dans la biosynthèse de benzo[c] phénantridines naturelles. Le composé (2) montre une puissante activité antibactérienne contre Staphylococcus aureus, avec une CMI50 = 4 μg·mL−1.

Compléments :
Des compléments sont fournis pour cet article dans le fichier séparé :

Métadonnées
Reçu le :
Accepté le :
Publié le :
DOI : 10.1016/j.crci.2015.01.005
Keywords: Zanthoxylum atchoum, Rutaceae, Alkaloids, Benzophenanthridines, Indolopyridoquinazolines
Mot clés : Zanthoxylum atchoum, Rutaceae, Alcaloïdes, Benzophénanthridines, Indolopyridoquinazolines
Philomène Akoua Yao-Kouassi 1, 2 ; Catherine Caron 1 ; Harisolo Ramiarantsoa 2 ; Élise Prost 1 ; Dominique Harakat 3 ; Élisabeth Le Magrex-Debar 4 ; Sophie C. Gangloff 4 ; Antoine Ahibo Coffy 2 ; Monique Zèches-Hanrot 1

1 Groupe « isolement et structure », institut de chimie moléculaire de Reims, CNRS UMR 7312, CPCBAI, bâtiment 18, moulin de la Housse, BP 1039, 51687 Reims cedex, France
2 Laboratoire de chimie organique biologique, université FHB Cocody-Abidjan, 22 BP 582, Abidjan, Cote d’Ivoire
3 Service commun d’analyses, institut de chimie moléculaire de Reims (ICMR), CNRS UMR 7312, bâtiment 18, BP 1039, 51687 Reims cedex 2, France
4 Laboratoire de microbiologie, EA « biomatériaux et inflammation en site osseux », UFR de pharmacie, 1, rue du Maréchal-Juin, 51096 Reims cedex, France
@article{CRCHIM_2015__18_8_891_0,
     author = {Philom\`ene Akoua Yao-Kouassi and Catherine Caron and Harisolo Ramiarantsoa and \'Elise Prost and Dominique Harakat and \'Elisabeth Le Magrex-Debar and Sophie C. Gangloff and Antoine Ahibo Coffy and Monique Z\`eches-Hanrot},
     title = {New nitro-benzo[\protect\emph{c}]phenanthridine and indolopyridoquinazoline alkaloids from {\protect\emph{Zanthoxylum} atchoum}},
     journal = {Comptes Rendus. Chimie},
     pages = {891--897},
     publisher = {Elsevier},
     volume = {18},
     number = {8},
     year = {2015},
     doi = {10.1016/j.crci.2015.01.005},
     language = {en},
}
TY  - JOUR
AU  - Philomène Akoua Yao-Kouassi
AU  - Catherine Caron
AU  - Harisolo Ramiarantsoa
AU  - Élise Prost
AU  - Dominique Harakat
AU  - Élisabeth Le Magrex-Debar
AU  - Sophie C. Gangloff
AU  - Antoine Ahibo Coffy
AU  - Monique Zèches-Hanrot
TI  - New nitro-benzo[c]phenanthridine and indolopyridoquinazoline alkaloids from Zanthoxylum atchoum
JO  - Comptes Rendus. Chimie
PY  - 2015
SP  - 891
EP  - 897
VL  - 18
IS  - 8
PB  - Elsevier
DO  - 10.1016/j.crci.2015.01.005
LA  - en
ID  - CRCHIM_2015__18_8_891_0
ER  - 
%0 Journal Article
%A Philomène Akoua Yao-Kouassi
%A Catherine Caron
%A Harisolo Ramiarantsoa
%A Élise Prost
%A Dominique Harakat
%A Élisabeth Le Magrex-Debar
%A Sophie C. Gangloff
%A Antoine Ahibo Coffy
%A Monique Zèches-Hanrot
%T New nitro-benzo[c]phenanthridine and indolopyridoquinazoline alkaloids from Zanthoxylum atchoum
%J Comptes Rendus. Chimie
%D 2015
%P 891-897
%V 18
%N 8
%I Elsevier
%R 10.1016/j.crci.2015.01.005
%G en
%F CRCHIM_2015__18_8_891_0
Philomène Akoua Yao-Kouassi; Catherine Caron; Harisolo Ramiarantsoa; Élise Prost; Dominique Harakat; Élisabeth Le Magrex-Debar; Sophie C. Gangloff; Antoine Ahibo Coffy; Monique Zèches-Hanrot. New nitro-benzo[c]phenanthridine and indolopyridoquinazoline alkaloids from Zanthoxylum atchoum. Comptes Rendus. Chimie, Volume 18 (2015) no. 8, pp. 891-897. doi : 10.1016/j.crci.2015.01.005. https://comptes-rendus.academie-sciences.fr/chimie/articles/10.1016/j.crci.2015.01.005/

Version originale du texte intégral

1 Introduction

Zanthoxylum atchoum (Aké Assi), P.G. Waterman (Rutaceae) is an endemic straggling shrub distributed in humid forests of southern Ivory Coast. The plant is used to treat amenorrhea in traditional medicine. There has been no report of other phytochemical study and biological value of Zanthoxylum atchoum so far. In our continuous search for chemical bioactive constituents of Ivorian Zanthoxylum species [1], we investigated the methanol extract of Z. atchoum.

The present study deals with the isolation and structural elucidation of two new benzophenanthridine alkaloids, 6-nitronitidine (1) and 6-nitro-8-methoxy-7,8-dihydronitidine (2), and of two new indolopyridoquinazoline alkaloids, 3-hydroxydehydroevodiamine (3) and its zwitterionic form 3-hydroxylatedehydroevodiamine (4), along with 18 (522) known compounds.

This is the first report of a nitro group in the biosynthesis of new natural benzo[c]phenantridine alkaloids. We also report in the 1H NMR experiences an unusual hydrogen–deuterium exchange of the 8-methoxy hydrogens (CD3OD solvent) in compound 2. The antibacterial activities of compounds 1-4 were evaluated against Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus and Enterococcus faecalis.

2 Experimental

2.1 Apparatus

NMR spectra were recorded in CD3OD using a Bruker Avance DRX-500 spectrometer (1H at 500 MHz and 13C at 125 MHz), and 2D-NMR experiments were performed using Bruker's standard microprograms (XWIN-NMR version 2.6 software). HR–ESI–MS and EI experiments were obtained using a micromass Q-TOF micro instrument (Manchester, UK) and water-micromass GCT (UK). Ultraviolet spectra were recorded in MeOH on a Philips PU 8720 spectrophotometer. Infrared spectra were measured using a Nicolet Avatar 320 FT-IR spectrometer. Chromatography was performed on silica gel 60 (63–200 μm, Merck). Preparative glass-backed TLC plates, coated with silica gel 60 F254 (Merck) were used. TLC spots were visualized under UV light (254 and 365 nm) followed by spraying with Dragendorff's reagent for alkaloids or with 50% H2SO4 for the detection of other compounds.

2.2 Plant material

The plant was identified and collected by Prof. Aké Assi in April 2003 in Yapo (Agboville), Ivory Coast. A voucher specimen (Aké Assi 14820) was deposited in the National Herbarium of Floristic Center of University HFB Cocody-Abidjan.

2.3 Extraction and isolation

A total of 920 g of air-dried powdered roots of Zanthoxylum atchoum were successively extracted with petroleum ether and methanol for 48 h. After removal of the solvent, the petroleum ether and methanol extracts were repeatedly chromatographed on silica gel to give 22 compounds (122). The petroleum ether extract (2 g) was chromatographed over a silica gel column using a gradient system of cyclohexane/chloroform (5:5 to 0:1) and then chloroform/methanol (1:0 to 9:1) to give: 19 (102 mg), 8 (4 mg) and 22 (406 mg) (in C6H12/CHCl3: 5:5), 21 (15 mg) (with 100% CHCl3) and 20 (60 mg) (eluted with CHCl3/CH3OH: 99:1). The methanol extract (5 g) was fractionated into seven fractions (F1–F7) by vacuum liquid chromatography on silica gel using a gradient of mixtures of C6H12/CHCl3 (1:0 to 0:1) and CHCl3/MeOH (9:1 to 5:5).

The 100% CHCl3 fraction F4 (1.3 g) was subjected to silica gel column chromatography (CC) eluting with an increasing gradient of C6H12/CHCl3 (1:0 to 0:1) and CHCl3/MeOH (1:0 to 99:1) to give nine compounds. The C6H12/CHCl3 fractions gave 11 (32 mg) (C6H12/CHCl3, 7:3), 10 (15 mg) (C6H12/CHCl3, 5:5), 6 (107 mg) and 17 (158 mg) (100% CHCl3). The CHCl3/MeOH fractions yielded compounds 9 (12 mg) (CHCl3/MeOH, 199:1), 7 (10 mg), 18 (23.4 mg) (CHCl3/MeOH, 99:1) and 14 (10 mg) obtained by preparative TLC protocol (CH3OH/NH4NO2, 9:1).

The fractions F5 + F6 (1.8 g) (CHCl3/MeOH, 8:2) were subjected to CC on silica gel, eluting with CHCl3/MeOH (1:0 to 5:5) to afford 60 subfractions (A1 to A60).

Fractions A25–A28 (68 mg, CHCl3/MeOH, 95:5) were separated by preparative TLC eluting with CH3OH/NH4NO2 9:1 to give 16 (16 mg) and 13 (9 mg).

Fractions A30–A33 (80 mg, CHCl3/MeOH, 9:1) gave 15 (10 mg).

Fractions A35–A40 (160 mg, CHCl3/MeOH, 85:15) gave 12 (102 mg) and 5 (14 mg) by preparative TCL (CH3OH/NH4NO2 9:1).

Fractions A42–A45 (110 mg, CHCl3/MeOH, 8:2) gave 1 (10 mg) and 2 (8 mg) by preparative TCL (CH3OH/NH4NO2 9:1).

Fractions A48–A58 (98 mg, CHCl3/MeOH, 7:3) afforded 3 (9 mg) and 4 (5 mg) by preparative TCL (CH3OH/NH4NO2 9:1).

2.3.1 2,3-(methylenedioxy)-6-nitro-10,11-(dimethoxy)-7-methylbenzo[c]phenanthridinium or (6-nitronitidine) (1)

Yellow powder; UV (MeOH) λmax: 231, 266, 312 nm; IR (KBr): 3408, 2924, 1613, 1521, 1496, 1351, 1277, 1036 cm−1; 1H (CD3OD + TFA, 500 MHz) and 13C NMR (CD3OD + TFA, 125 MHz) data see Table 1; EIMS m/z 393 [M]+; Tandem MS/MS 393: m/z 393[M]+, 346 [M–NO2–H]+, 332 [M–NO2–CH3]+, 318 [M–NO2–OCH3 + 2H]+, 301 [M–NO2–OCH3–CH3]+; HRESIMS m/z 394.1348 [M + H]+(calcd. for C21H18N2O6, 394.1347).

Table 1

1H (500 MHz) and 13C NMR (125 MHz) spectroscopic data for compounds 1 and 2.

12
PositionδC ppmδH ppm [mult, J (Hz)]δC ppmδH ppm [mult, J (Hz)]
1106.08.17 (s)101.07.71 (s)
2a153.5152.0
3a154.0152.5
4108.07.68 (s)106.07.33 (s)
4a132.0130.0
5128.08.63 (s)121.07.99 (s)
6144.0144.0
8155.09.82 (s)92.05.25 (s)
8a122.0121.0
9110.07.93 (s)112.07.13 (s)
10155.0150.0
11160.0150.0
12105.07.41 (s)110.06.85 (s)
13119.0119.0
12a133.0127.0
14138.0141.0
14a123.0130.5
OCH2O103.06.33 (s)104.06.15 (s)
10-OCH358.04.07 (s)57.03.93 (s)
11-OCH358.04.12 (s)57.03.79 (s)
8-OCH3
N-CH3

53.0

4.93 (s)
55.0
40.0
3.50 (s)
2.68 (s)

a Interchangeable, 1H and 13C recorded in CD3OD.

2.3.2 2,3-methylenedioxy-6-nitro-8,10,11-trimethoxy-7-methylbenzo[c]phenanthridine or 6-nitro-8-methoxy-7, 8-dihydronitidine (2)

Yellow powder; UV (MeOH) λmax: 271, 293, 307, 328; IR (KBr): 3408, 1615, 1502, 1470, 1384, 1284, 1209, 1036 cm−1; 1H (CD3OD, 500 MHz) and 13C NMR (CD3OD, 125 MHz) data see Table 1; ESIMS: m/z 871 [M + Na + M]+, 447 [M + Na]+, 393[M- OCH3]+; HRESIMS m/z 425.1349 [M + H]+ (calcd. for C22H21N2O7, 425.1343).

2.3.3 3-hydroxy-8,13-dihydro-14-methyl-5-oxo-7H-indolo[2′,3′:3,4]pyrido[2,1-b]quinazolin-14-ium or 3-hydroxydehydroevodiamine (3)

Yellow powder; UV (MeOH) λmax: 214, 245, 330, 368, 381 nm; IR (KBr): 3063, 2920, 1692 cm−1; EI m/z: 318 [M]+.; 1H (CD3OD, 500 MHz) and 13C NMR (CD3OD, 125 MHz); data see Table 2. Elementary analysis: C 62.36%, H 5.40%, N 9.01% for C19H16N3O2.

Table 2

1H and 13C NMR data of compounds 3 and 4. δ in ppm, J in Hz.

34
PositionδCδH (mult, J)δCδH (mult, J)
1121.27.96 (d, J = 9.7)120.27.65 (d, J = 9.2)
2126.37.55 (dd, J = 9.7, 2.8)130.57.22 (dd, J = 9.2, 3)
3159.8170.4
4113.07.72 (d, J = 2.8)114.87.32 (d, J = 3)
4a122.0121.7
5159.4159.7
743.64.58 (t, J = 6.7)43.54.50 (t, J = 7.0)
820.03.33 (t, J = 6.7)20.13.34 (t, J = 7.0)
8a131.8129.8
9122.47.85 (d, J = 8.2)122.07.85 (d, J = 8.2)
9a125.2125.4
10123.27.30 (t, J = 7.7)122.87.26 (t, J = 7.5)
11130.27.56 (t, J = 7.7)129.27.48 (t, J = 7.5)
12114.27.65 (d, J = 8.4)114.27.63 (d, J = 8.4)
12a143.1147.8
13a121.9121.9
13b149.6146.5
14a133.9128.9
NCH341.14.40 (s)40.84.35 (s)

2.3.4 3-phenolate-8,13-dihydro-14-methyl-5-oxo-7H-indolo[2′,3′:3,4]pyrido[2,1-b]quinazolin-14-ium or 3-hydroxylatedehydroevodiamine (4)

Orange powder; EI m/z: 317 [M]+., 1H (CD3OD, 500 MHz) and 13C NMR (CD3OD, 125 MHz); data see Table 2.

2.3.5 (–)-Evodiamine (6)

Yellow brilliant crystal; [α]D = –522°(C= 0.54, CH3OH),–642° (C = 0.67, CHCl3); UV (MeOH) λmax: 225, 272, 284, 293 nm; IR (KBr): 3582, 3269, 3063, 2920, 1637, 1605, 1480, 1424, 1306, 1031, 745 cm−1; ESI m/z: 304 [M + H]; 1H (CDCl3, 500 MHz): 2.50 (N-CH3, s), 2.98 (H-8, m), 3.30 (H-7b, ddd, 15.7, 10.7, 5), 4.89 (H-7a, ddd, 10.7, 5, 2.6), 5.92 (H-13b, s), 7.15 (H-1, d, 8), 7.21 (H-10, t, 7.5), 7.23 (H-3, t, 8), 7.27 (H-11, t,7.2), 7.43 (H-12, d, 8.0), 7.49 (H-2, t, 8), 7.60 (H-9, d, 8.2), 8.13 (H-4, d, 8), 8.31 (NH, s), 13C NMR (CDCl3, 125 MHz): 20.1 (C-8), 37.2 (CH3), 39.5 (C-7), 68.8 (C-13b), 111.3 (C-12), 113.6 (C-8a), 118.9 (C-9), 120.0 (C-10), 122.4 (C-1), 123.0 (C-11), 123.7 (C-4a), 124.1 (C-3), 126.2 (C-9a), 128.2 (C-13a), 128.9 (C-4), 133 (C-2), 136.7 (C-12a), 150.6 (C-14a), 164.7 (C-5).

2.4 Antibacterial assays

The assay for antibacterial activity against standard strains Staphylococcus aureus (ATCC 25923), Enterococcus faecalis (29212), Escherichia coli (ATCC 25922), and Pseudomonas aeruginosa (ATCC 27853) was performed using the liquid microdilution growth inhibition method (Grare et al., 2006) [2]. Antibacterial agents used for positive controls were vancomycin for Gram+ and imipenem for Gram–strains. The MICs of test compounds were determined as described in the previous study by Yao-Kouassi et al. (2008) [3].

3 Results and discussion

The root bark of Z. atchoum was extracted successively with petroleum ether and methanol. The extracts were chromatographed on silica gel to afford 22 compounds 122. Structural elucidation of these compounds was performed using spectroscopic methods, especially 1D and 2D-NMR, HR-EI MS, UV and IR.

Compound 1 was isolated as a yellow powder. The UV spectrum showed absorptions at 271, 293, 309, 328 and 390 nm, which are characteristic of the benzo[c]phenanthidine skeleton [4]. The HRESIMS spectrum displayed the molecular ion [M + H]+ at m/z 394,1348 (calcd for 394.1347), which, in combination with 1H and 13C NMR spectroscopy and IR data, indicated molecular formula C21H17N2O6.

The 1H-NMR spectrum (Table 1) of 1 revealed only ten singlet signals due to six aromatic proton resonances at δH 8.17 (1H, s, H-1), 7.68 (1H, s, H-4), 8.63 (1H, s, H-5), 9.82 (1H, s, H-8), 7.93(1H, s, H-9), and 7.41(1H, s, H-12), one methylenedioxy group at 6.33 (2H, s, O–CH2–O) and three methyl groups assignable to two methoxy groups at 4.07 (3H, s, 10-OCH3), 4.12 (3H, s, 11-OCH3) and one N-methyl group at 4.93. In agreement with the above, the 13C NMR of compound 1 showed resonances for 21 C-atoms, including 11 quaternary carbons, six methines, one methylene and three methyl groups (Table 1).

The 1H NMR and 13C NMR signals of compound 1 were closely related to those of nitidine (8), except for the absence of one aromatic proton and the presence of one more quaternary carbon, suggesting that 1 was certainly an ortho-pentasubstituted benzo[c]phenanthidine [4]. Total assignments of protons H-1, H-4, H-5, H-8, H-9, H-12 and of the methyl groups were clearly obtained from the NOESY and HMBC experiments (Fig. 1). The location of the N-methyl group and of proton H-1 were secured by the NOE interaction between H-1 at δH 8.17 and N-Me at δH 4.93; in addition, both protons and the deshielded proton at δH 9.82 (H-8) showed long-range connectivity with the signal at δC 138.0 (C-14). The HMBC interactions between the protons at δH 6.33, 8.17 and 7.68 (H-4) and carbons at δC 153.5 (C-2) and 152.9 (C-3) suggested that the methylenedioxy group was connected to C-2 and C-3 on the ring D. Furthermore, the NOESY spectrum displayed a significant cross-peak between H-4 and the proton at δH 8.63, which was unequivocally assigned to H-5, and the proton H-9 at δH 7.93 was assigned by its cross-peak between H-8. Thus H-12 was assigned to δH 7.41, confirming its long-range correlations with C-8a at δC 122.0 and C-13 at δC 119.0. The location of the two methoxy groups at C-10 and C-11 were established by HMBC correlations of protons at δH 4.07 to C-10 (δC 155.0) and 4.12 to C-11 (δC 160.0), and were confirmed by the NOESY correlations between H-9/Me-10 and H-12/Me-11. The HMBC correlations between H-5 and C-6 (δC 144.0) suggested that a heteroatom, presumably a nitro group, was certainly attached to C-6. This was in accordance with the upfield shift of C-6 and consequently inferred that 1 was a 2,3,6,10,11-ortho-pentasubstituted benzophenanthridine alkaloid. The IR spectrum of 1 showed two strong bands at 1521 and 1351 cm–1 which can be ascribed to N-O stretching of the nitro group. In addition, the presence of the nitro group was confirmed by the fragmentation MS/MS of the molecular ion [M]+ at m/z 393, which gave a series of ions at m/z 346, 332, 318 and 301, from which the loss of a nitro group was respectively deduced as follows: [M–NO2–H]+, [M–NO2–CH3]+, [M–NO2–OCH3 + 2H]+ and [M–NO2–OCH3–CH3]+. Thus, compound 1 was characterized as 2,3-(methylenedioxy)-6-nitro-10,11-(dimethoxy)-7-methylbenzo[c]phenanthridinium, to which we gave the trivial name 6-nitronitidine. This is the first occurrence of a natural benzylisoquinoline alkaloid with a nitro group on the C ring of the benzo[c]phenanthidine nucleus isolated from Zanthoxylum atchoum. The presence of the nitro group seems to be scarce in the plant kingdom, regardless of special phenanthrene derivatives mentioned in the Aristolochia genus [5]. Furthermore, several examples of C-6 substituted on the C ring of benzophenanthridines do exist, but it concerns 6-O-alkyl compounds in which the C ring is not completely aromatic [6,7].

Fig. 1

(Color online.) Selected HMBC and NOESY correlations for compound 1.

Compound 2 was obtained as a yellow amorphous solid. Its molecular formula was deduced as C22H20N2O7 by positive-ion mode HRESIMS [M + H]+ at m/z 425.1349 (calcd for 425.1349). Comparison of the NMR data (Table 1) of 2 to those of 1 indicated a slight modification of the iminium bond CN at C-8. Instead of the aromatic methine proton at C-8, the signals detected were those of the methine proton at δH 5.25 (1H, s, H-8) and of a methoxy group at δH 3.50 (3H, s, 8-OCH3) in the 1H-NMR spectrum. The location of this methoxy group was confirmed by the NOE correlation between the –OMe and H-8. Compound 2 seems to be the pseudo base of 1 and was characterized as 6-nitro-8-methoxy-7,8-dihydronitidine (Fig. 2).

Fig. 2

Structures of compounds 16.

This kind of product is well known among the quaternary benzo[c]phenanthridine alkaloid-free bases and detailed structural and NMR studies have already been reported by Dostal et al. [8,9]. Surprisingly enough, the signal of this methoxy group at δH 3.5 was gradually vanished within 24 h, whereas the signal of the residual solvent (MeOH) at δH 3.38 was increased (Fig. 3). Fig. 3 shows the 1H-NMR spectrum of 2, in which t1 and t3 represent respectively the beginning and the end of the experiments. It is remarkable that the protons of the 8-OCH3 group were H–D exchanged during the 1H-NMR experiments by the deuterated solvent (CD3OD) (Fig. 3). This situation made very difficult the NMR interpretation because of the bewildering assignment of the 8-OCH3 or OH group in benzophenanthridine pseudo-base compounds. In our study, deuterium retention of the 8-OCH3 to 8-OCD3 was confirmed by mass spectra with 3 amu more than in 1.

Fig. 3

H-D exchanged in the 1H-NMR experiments by CD3OD solvent.

Compound 3 was isolated as a yellow amorphous solid. Our EI mass spectra evidenced the positive ion [M]+ at m/z 318, which is consistent with the molecular formula C19H16N3O2. The IR spectrum of 3 implied the presence of hydroxyl and NH groups (3000–3063 cm−1) and of the amide carbonyl group (1692 cm−1). The UV spectrum showed absorptions bands at 250, 330 and 380 nm, with a bathochromic shift observed in alkaline medium at 417 nm, suggesting the presence of a phenol group. The 1H-NMR spectrum of 3 showed four aromatic protons of an 1,2-ortho-disubstituted phenyl ring at δH 7.85 (1H, d, J = 8.2 Hz, H-9), 7.30 (1H, t, J = 7.7, H-10), 7.56 (1H, t, J = 7.7 Hz, H-11), 7.65 (1H, d, J = 8.4 Hz, H-12), three aromatic proton signals at δH 7.96 (1H, d, J = 9.7 Hz, H-1), 7.55 (1H, dd, J = 9.7, 2.8 Hz, H-2) and 7.72 (1H, d, J = 2.8 Hz, H-4), revealing the presence of an ABX system in a 1,3,4-trisubstituted phenyl ring, one methyl singlet group at δH 4.40 (3H, s, N-CH3), and two methylene groups at δH 4.58 (2H, t, J = 6.7 Hz, H-7) and 3.33 (2H, t, J = 6.7 Hz, H-8). All these data readily help us to identify a typical 7, 8-dihydropyridoquinazoline nucleus [10,11]. The 13C-NMR spectrum of 3 showed 19 carbon signals due to eight quaternary carbons, seven methines, two methylenes, N-methyl and carbonyl groups. The 1H and 13C NMR spectra (Table 2) of 3 were similar to those of dehydroevodiamine (5) [12], except for the increase of chemical shift of C-3. According to the preceding data, 3 was suggested to be a 3-hydroxy analog of 5 and similar to those described by Li et al., 2001 [13]. The protons H-9 and H-1 were assigned by the NOESY spectrum, which showed respectively cross-peaks between H-9/H-8 and H-1/N–CH3 (Fig. 4). The location of the hydroxy at C-3 was confirmed by the HMBC experiment, which showed correlations between the protons H-1, H-2 and H-4 and C-3 (δC 159.8) (Fig. 4). Thus, on the basis of spectral evidence, the structure of compound 3 was elucidated as a salt of 3-hydroxy-8,13-dihydro-14-methyl-5-oxo-7H-indolo[2’,3’:3,4]pyrido[2,1-b]quinazolin-14-ium, to which we gave the trivial name of 3-hydroxydehydroevodiamine.

Fig. 4

(Color online.) Selected HMBC and NOESY correlations for compounds 3.

Compound 4 was obtained as an orange amorphous solid. A molecular ion peak at m/z [M]+ 317 suggested its molecular formula C19H15N3O2, which was one proton less than in that of 3.

Furthermore, the NMR data of 4 were similar to those of 3. However, the 13C NMR spectrum of 4 showed the presence of a deshielding C-3 at δC 170.4 instead of 159.8; this means that 4 is the zwitterionic 3-phenolate form of 3, named 3-phenolatedehydroevodiamine (Fig. 2).

The known compounds (523) were readily identified, from their spectral data and by comparison with reported corresponding compounds in the literature, as dehydroevodiamine (5), evodiamine (6) [14], decursinol (7) [15], asarinin (8) [16], oxynitidine (9), norchelerythrine (10) [17], tridecanonchelerythrine (11) [18], nitidine (12), chelerythrine (13), methoxychelerythrine (14), fagaridine (15), methoxyfagaridine (16), arnottianamide (17), pellitorine (18), sesamin (19), skimmianine (20), stigmasterol (21), and lupeol (22). Compounds 1223 were previously found in other Ivorian Zanthoxylum species [1]. We describe the structural elucidation and configuration of 13b αH of compound 6 which displayed negative values: [α]D = –522° (c 0.54 in CH3OH) and–642° (c 0.67 in CHCl3) for optical rotation, like that of the synthesized one [19]. Nevertheless, the isolated evodiamine described in literature was optically inactive or displayed positive optical rotation values [20–22].

The isolated new compounds (14) were evaluated for their antibacterial activities against four pathogenic microorganisms, E. coli, P. aeruginosa, S. aureus, and E. faecalis; the results are summarized in Table 3. Among them, compound 2 was the most active one, with MICs of 4, 8, 16, and 32 μg·mL−1 against S. aureus, E. faecalis, P. aeruginosa, and E. coli, respectively (Table 3). Compound 1 exhibited mild activity against these four bacteria with MICs of 32 μg·mL−1. This result suggested that the pseudo base of these isolated nitro benzophenanthridine is more active than the ammonium quaternary 1. A similar antimicrobial effect was observed with sanguinarine and chelerythrine and their pseudo bases [23].

Table 3

Antibacterial activity of isolated compounds 14.

Test materialsMIC μg·mL−1
S. aureusE. coliE. faecalisP. aeruginosa
132323232
2432816
364646464
46412864128

4 Conclusions

This work constituted the first phytochemical study of Z. acthoum. The methanolic extract of the roots led to the isolation of 11 benzophenanthridines, four indolopyridoquinazoline, one furanoquinoline alkaloids, two lignans, one coumarin, one amid, one triterpene, and one phytosterol. Among them, 6-nitronitidine (1), 6-nitro-8-methoxy-7,8-dihydronitidine (2), 3-hydroxydehydroevodiamine (3), and 3-phenolatedehydroevodiamine (4) were characterized as new compounds. This paper reports the first natural nitro group on the benzophenanthridine nucleus. This work allowed us to understand the fickle behavior of benzophenanthridine bases towards solvents, in particular deuterium retention of the OCH3 to OCD3, which made difficult the interpretation of the spectra. The antibacterial activities against two gram-positive (S. aureus and E. faecalis) and two gram-negative (E. coli and P. aeruginosa) strains for compounds 14 were tested. Compound 2 showed strong antibacterial activity against S. aureus at the concentration of MIC50 4 μg·mL−1.

Acknowledgements

The authors thank Prof. C. Lavaud and Dr. J.-M. Nuzillard for profitable scientific exchanges, and are grateful to CNRS UMR 7312 France and Government of Ivory Coast for financial support. The authors would like to pay a tribute to the Prof. Aké Assi L. (University FHB Cocody-Abidjan) for the identification of the plant.


Bibliographie

[1] P.A. Yao-Kouassi; A. Martinez; D.F. Malan; D.E. Le Magrex; S.C. Gangloff; C. Caron; A.A. Coffy; M. Zèches-Hanrot Int. J. Biol. Chem. Sci., 8 (2014), p. 377

[2] M. Grare; M. Mourer; J.B. Regnouf-de-Vains; C. Finance; R.E. Duval Pathol. Biol., 54 (2006), p. 470

[3] P.A. Yao-Kouassi; A.A. Magid; B. Richard; A. Martinez; M.J. Jacquier; C. Caron; D.E. Le Magrex; S.C. Gangloff; A.A. Coffy; M. Zèches-Hanrot J. Nat. Prod., 71 (2008), p. 2073

[4] B.D. Krane; M.O. Fagbule; M. Shamma; B. Gözler J. Nat. Prod., 47 (1984), p. 1

[5] T.S. Wu; Y.Y. Chan; Y.L. Leu; P.L. Wu; C.Y. Li; Y. Mori J. Nat. Prod., 62 (1999), p. 348

[6] K. Iwasa; N. Takao; G. Nonaka; I. Nishioka Phytochemistry, 18 (1979), p. 1725

[7] W.G. Ma; Y. Fukushi; S. Tahara Fitoterapia, 70 (1999), p. 258

[8] J. Dostal; E. Taborska; J. Slavik J. Nat. Prod., 58 (1995), p. 723

[9] J. Dostal; R. Marek; J. Slavik; E. Taborska; M. Potacek; V. Sklenar Magn. Reson. Chem., 36 (1998), p. 869

[10] A.H. Januário; P.C. Vieira; M.F.G.F. da Silva; J.B. Fernandes; J.J.B. Silva; L.M. Conserva Quim. Nova, 32 (2009), p. 2034

[11] C. Ezugwu; E. Bedir; C. Dunbar; I.A. Khan; C.O. Okunji; B.M. Schuster; M.M. Iwu Helv. Chim. Acta, 86 (2003), p. 2914

[12] M. Arisawa; T. Horiuchi; T. Hayashi; Y. Tezuka Chem. Pharm. Bull., 41 (1993), p. 1472

[13] X.C. Li; D.C. Dunbar; H.N. Elsohly; L.A. Walker; A.M. Clark Phytochemistry, 58 (2001), p. 627

[14] R. Lui; X. Chu; A. Sun; L. Kong Chromatography A, 1074 (2005), p. 139

[15] S.Y. Kang; K.Y. Lee; S.H. Sung; Y.C. Kim J. Nat. Prod., 68 (2005), p. 56

[16] S. Wimalasena; E. Karunawansha J. Nat. Sci. Coun. Sri Lanka, 22 (1994), p. 301

[17] I.S. Chen; Y.C. Lin; I.L. Tsai; M.C. Teng; F.N. Ko; T. Ishikawa; H. Ishii Phytochemistry, 39 (1995), p. 1091

[18] C.M. Jen; I.L. Tsai; D.J. Horng; S.I. Chen J. Nat. Prod., 56 (1993), p. 2019

[19] K. Komatsu; K. Wakame; Y. Kano Biol. Pharma. Bull., 16 (1993), p. 935

[20] K.W. Gopinath; T.R. Govindachari; V.R. Rao Tetrahedron, 8 (1960), p. 293

[21] B.S. Joshi; K.M. Moore; S.W. Pelletier Phytochem. Anal., 2 (1991), p. 20

[22] The Merk Index: an Encyclopedia of chemicals, drugs and biologicals (M.J. O’Neil; A. Smith; P.E. Heckelman; J.J.R. Obenchain; J.A.R. Gallipeau; M.A. D’Arecca, eds.), Merck & Co., Inc., Whitehouse Station (NJ), 2001, p. 691

[23] M.L. Colombo; E. Bosisio Pharmacol. Res., 33 (1996), p. 127


Commentaires - Politique


Ces articles pourraient vous intéresser

Chlorotrimethylsilane catalyzed synthesis of 1,3-diphenyl-2-propenones and their antimicrobial activities

Progyashree Goswami; Madhumita Talukdar; Tarun C. Bora; ...

C. R. Chim (2013)


Synthesis, spectroscopy and electrochemistry of new 4-(4-acetyl-5- substituted-4, 5-dihydro-1, 3,4-oxodiazol-2-yl)methoxy)-2H-chromen-2-ones as a novel class of potential antibacterial and antioxidant derivatives

N. Hamdi; V. Passarelli; A. Romerosa

C. R. Chim (2011)


Synthesis, functionalization and properties of incompletely condensed “half cube” silsesquioxanes as a potential route to nanoscale Janus particles

Michael Z. Asuncion; Marco Ronchi; Haya Abu-Seir; ...

C. R. Chim (2010)